Skip to content
10-K

Annual Report

Insight Molecular Diagnostics Inc. IMDX

0001642380-26-000004

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 32.17M sh
Shares Diluted FY 2025 · Dec 31, 2025 30.48M sh
Shares Diluted FY 2025 · Dec 31, 2024 13.07M sh
Capex FY 2025 · Dec 31, 2025 $3.19M
Capex FY 2025 · Dec 31, 2024 $516K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$22.18M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$20.69M
Cash And Equivalents FY 2025 · Dec 31, 2025 $11.58M
Cash And Equivalents FY 2025 · Dec 31, 2024 $8.64M
Stockholders Equity FY 2025 · Dec 31, 2025 −$31.46M
Stockholders Equity FY 2025 · Dec 31, 2024 −$12.27M
Stockholders Equity FY 2025 · Dec 31, 2023 $20.47M
Current Liabilities FY 2025 · Dec 31, 2025 $12.08M
Current Liabilities FY 2025 · Dec 31, 2024 $7.28M
Total Liabilities FY 2025 · Dec 31, 2025 $57.22M
Total Liabilities FY 2025 · Dec 31, 2024 $47.36M
Current Assets FY 2025 · Dec 31, 2025 $15.31M
Current Assets FY 2025 · Dec 31, 2024 $11.76M
Total Assets FY 2025 · Dec 31, 2025 $25.76M
Total Assets FY 2025 · Dec 31, 2024 $35.08M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.65
Eps Diluted FY 2025 · Dec 31, 2024 −$4.66
Eps Basic FY 2025 · Dec 31, 2025 −$1.65
Eps Basic FY 2025 · Dec 31, 2024 −$4.66
Sga Expense FY 2025 · Dec 31, 2025 $10.63M
Sga Expense FY 2025 · Dec 31, 2024 $10.2M
Rd Expense FY 2025 · Dec 31, 2025 $15.9M
Rd Expense FY 2025 · Dec 31, 2024 $9.84M
Net Income FY 2025 · Dec 31, 2025 −$50.22M
Net Income FY 2025 · Dec 31, 2024 −$60.66M
Operating Income FY 2025 · Dec 31, 2025 −$51.12M
Operating Income FY 2025 · Dec 31, 2024 −$61.04M
Gross Profit FY 2025 · Dec 31, 2025 $2.3M
Gross Profit FY 2025 · Dec 31, 2024 $740K
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.75M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.05M
Revenue FY 2025 · Dec 31, 2025 $4.06M
Revenue FY 2025 · Dec 31, 2024 $1.88M